Insights Into T2 Biosystems Inc. (TTOO) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for T2 Biosystems Inc. (TTOO) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.0001, or -0.10%, to $0.1014. Volume reached 1,076,598 shares, with price reaching a high of $0.1045 and a low of $0.0997. Most recently, Yahoo Finance reported about the stock as it publicized that T2 Biosystems to Participate in the H.C. Wainwright Global Investment Conference.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.

Sponsored

Stocks Info

T2 Biosystems Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $0.10 and fluctuated between $0.1060 as its day high and $0.0990 as its day low. The current market capitalization of T2 Biosystems Inc. is $37.79M. A total of 17.31 million shares were traded on the day, compared to an average of 41.45M shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, TTOO has seen 9 BUY and 0 SELL insider trades, representing the acquisition of 516,268 and the disposition of 0 shares. Over the last 12 months, there were 29 BUYs and 10 SELLs from insiders. Insiders purchased 1,743,596 shares during that period but sold 423,474.

In the most recent transaction, Sprague John M bought 10,000 shares of TTOO for 0.48 per share on Apr 08. After the transaction, the Chief Financial Officer now owns 152,350 company shares. In a previous transaction on Apr 08, Giffin Brett A. bought 10,600 shares at 0.49 per share. TTOO shares that Chief Commercial Officer owns now total 10,600.

Among the insiders who bought shares, Barclay Alec acquired of 12,952 shares on Apr 08 at a per-share price of $0.50. This resulted in the Chief Operations Officer holding 181,945 shares of TTOO after the transaction. In another insider transaction, Gibbs Michael Terrence bought 10,000 shares at $0.49 per share on Apr 07. Company shares held by the General Counsel now total 166,651.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for TTOO in the last 3 months, the mean price target is $0.20 with high estimates of $0.25 and low estimates of $0.14. In terms of 52-week highs and lows, TTOO has a high of $1.08 and a low of $0.10.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 3 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TTOO is Buy with a score of 3.00. A total of 1 analysts rated the stock as Buy while 0 rated it as Overweight while 2 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

292
294

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.